血清瘦素及可溶性瘦素受体在诊断非酒精性脂肪肝合并肝纤维化中的价值
龚尚红 曹雨石 郑小蝶 秦芳怡 杜晓晨 徐巧本


【摘要】 目的:观察血清瘦素(LP)及可溶性瘦素受体(SLP)在诊断非酒精性脂肪肝(NAFLD)合并肝纤维化中的价值。方法:选取2018年5月-2019年5月本院收治的72例NAFLD患者作为NAFLD组。同期选择35例本院门诊健康体检者作为对照组。根据非酒精性脂肪性肝纤维化评分(nonalcoholic fatty liver disease fibrosis score,NAFLDFS)将NAFLD组分为NAFLD无肝纤维化组(A组,NAFLDFS0.05);LP、SLP诊断NAFLD患者合并肝纤维化的AUC、敏感度及特异度均优于PCⅢ、Ⅳ型胶原、LN、HA、FBG。结论:血清LP及SLP在诊断NAFLD合并肝纤维化方面具有较好的临床价值。
【关键词】 瘦素 可溶性瘦素受体 非酒精性脂肪肝 肝纤维化
The Value of Serum LP and SLP in the Diagnosis of Non-alcoholic Fatty Liver Disease with Liver Fibrosis/GONG Shanghong, CAO Yushi, ZHENG Xiaodie, QIN Fangyi, DU Xiaochen, XU Qiaoben. //Medical Innovation of China, 2021, 18(13): 0-064
[Abstract] Objective: To observe the value of serum LP and SLP in the diagnosis of non-alcoholic fatty liver disease (NAFLD) with liver fibrosis. Method: A total of 72 patients with NAFLD admitted to our hospital from May 2018 to May 2019 were selected as the NAFLD group. During the same period ......
您现在查看是摘要页,全文长 9526 字符。